Medical device

Download the Scientific Summary from NextGen Biomed

Presentation summary + key takeaways from Leukocare’s talk

This short summary highlights:

  • What computational tools can – and cannot – do in formulation

  • How to prioritize excipients earlier

  • How to reduce formulation risk and trial-and-error

Identification of relevant analytical methods for adeno-associated
virus stability assessment during formulation development